These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 10521408)
1. Identification of a cytoplasmic-retention sequence in ERK2. Rubinfeld H; Hanoch T; Seger R J Biol Chem; 1999 Oct; 274(43):30349-52. PubMed ID: 10521408 [TBL] [Abstract][Full Text] [Related]
2. Identification of a C-terminal region that is required for the nuclear translocation of ERK2 by passive diffusion. Shibayama S; Shibata-Seita R; Miura K; Kirino Y; Takishima K J Biol Chem; 2002 Oct; 277(40):37777-82. PubMed ID: 12149268 [TBL] [Abstract][Full Text] [Related]
3. Involvement of the activation loop of ERK in the detachment from cytosolic anchoring. Wolf I; Rubinfeld H; Yoon S; Marmor G; Hanoch T; Seger R J Biol Chem; 2001 Jul; 276(27):24490-7. PubMed ID: 11328824 [TBL] [Abstract][Full Text] [Related]
4. Nuclear shuttling of mitogen-activated protein (MAP) kinase (extracellular signal-regulated kinase (ERK) 2) was dynamically controlled by MAP/ERK kinase after antigen stimulation in RBL-2H3 cells. Furuno T; Hirashima N; Onizawa S; Sagiya N; Nakanishi M J Immunol; 2001 Apr; 166(7):4416-21. PubMed ID: 11254696 [TBL] [Abstract][Full Text] [Related]
5. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Robinson MJ; Stippec SA; Goldsmith E; White MA; Cobb MH Curr Biol; 1998 Oct; 8(21):1141-50. PubMed ID: 9799732 [TBL] [Abstract][Full Text] [Related]
6. Biochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2. Eblen ST; Catling AD; Assanah MC; Weber MJ Mol Cell Biol; 2001 Jan; 21(1):249-59. PubMed ID: 11113199 [TBL] [Abstract][Full Text] [Related]
7. Identification of novel point mutations in ERK2 that selectively disrupt binding to MEK1. Robinson FL; Whitehurst AW; Raman M; Cobb MH J Biol Chem; 2002 Apr; 277(17):14844-52. PubMed ID: 11823456 [TBL] [Abstract][Full Text] [Related]
8. Interaction of mitogen-activated protein kinases with the kinase interaction motif of the tyrosine phosphatase PTP-SL provides substrate specificity and retains ERK2 in the cytoplasm. Zúñiga A; Torres J; Ubeda J; Pulido R J Biol Chem; 1999 Jul; 274(31):21900-7. PubMed ID: 10419510 [TBL] [Abstract][Full Text] [Related]
9. Hydrophobic as well as charged residues in both MEK1 and ERK2 are important for their proper docking. Xu Be ; Stippec S; Robinson FL; Cobb MH J Biol Chem; 2001 Jul; 276(28):26509-15. PubMed ID: 11352917 [TBL] [Abstract][Full Text] [Related]
10. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity. Bardwell AJ; Abdollahi M; Bardwell L Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172 [TBL] [Abstract][Full Text] [Related]
11. Role of non-phosphorylated activation loop residues in determining ERK2 dephosphorylation, activity, and subcellular localization. Bendetz-Nezer S; Seger R J Biol Chem; 2007 Aug; 282(34):25114-22. PubMed ID: 17597065 [TBL] [Abstract][Full Text] [Related]
12. A bipartite mechanism for ERK2 recognition by its cognate regulators and substrates. Zhang J; Zhou B; Zheng CF; Zhang ZY J Biol Chem; 2003 Aug; 278(32):29901-12. PubMed ID: 12754209 [TBL] [Abstract][Full Text] [Related]
13. The death effector domain protein PEA-15 prevents nuclear entry of ERK2 by inhibiting required interactions. Whitehurst AW; Robinson FL; Moore MS; Cobb MH J Biol Chem; 2004 Mar; 279(13):12840-7. PubMed ID: 14707138 [TBL] [Abstract][Full Text] [Related]
14. The N-terminal ERK-binding site of MEK1 is required for efficient feedback phosphorylation by ERK2 in vitro and ERK activation in vivo. Xu Be; Wilsbacher JL; Collisson T; Cobb MH J Biol Chem; 1999 Nov; 274(48):34029-35. PubMed ID: 10567369 [TBL] [Abstract][Full Text] [Related]
15. ERK2 enters the nucleus by a carrier-independent mechanism. Whitehurst AW; Wilsbacher JL; You Y; Luby-Phelps K; Moore MS; Cobb MH Proc Natl Acad Sci U S A; 2002 May; 99(11):7496-501. PubMed ID: 12032311 [TBL] [Abstract][Full Text] [Related]
16. Different domains of the mitogen-activated protein kinases ERK3 and ERK2 direct subcellular localization and upstream specificity in vivo. Robinson MJ; Xu Be BE; Stippec S; Cobb MH J Biol Chem; 2002 Feb; 277(7):5094-100. PubMed ID: 11741894 [TBL] [Abstract][Full Text] [Related]
17. Direct monitoring of the expression of the green fluorescent protein-extracellular signal-regulated kinase 2 fusion protein in transfected cells using capillary electrophoresis with laser-induced fluorescence detection. Yoon S; Ban E; Yoo YS J Chromatogr A; 2002 Nov; 976(1-2):87-93. PubMed ID: 12462599 [TBL] [Abstract][Full Text] [Related]
18. Two clusters of residues at the docking groove of mitogen-activated protein kinases differentially mediate their functional interaction with the tyrosine phosphatases PTP-SL and STEP. Tárrega C; Blanco-Aparicio C; Muñoz JJ; Pulido R J Biol Chem; 2002 Jan; 277(4):2629-36. PubMed ID: 11711538 [TBL] [Abstract][Full Text] [Related]
19. ERK2 shows a restrictive and locally selective mechanism of recognition by its tyrosine phosphatase inactivators not shared by its activator MEK1. Tárrega C; Ríos P; Cejudo-Marín R; Blanco-Aparicio C; van den Berk L; Schepens J; Hendriks W; Tabernero L; Pulido R J Biol Chem; 2005 Nov; 280(45):37885-94. PubMed ID: 16148006 [TBL] [Abstract][Full Text] [Related]